Capital International Sarl Legend Biotech Corp Transaction History

Capital International Sarl

$3.71 Billion
Q3 2024

A detailed history of Capital International Sarl transactions in Legend Biotech Corp stock. As of the latest transaction made, Capital International Sarl holds 63,338 shares of LEGN stock, worth $2.26 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

63,338

Previous 93,786 32.47%

Holding current value

$2.26 Million

Previous $4.15 Million 25.69%

% of portfolio

0.08%

Previous 0.13%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$43.55 - $59.88 $1.33 Million - $1.82 Million	-30,448 Reduced 32.47%	63,338 $3.09 Million
Q2 2024 Aug 13, 2024	BUY	$39.5 - $57.22 $426,007 - $617,117	10,785 Added 12.99%	93,786 $4.15 Million
Q4 2023 Feb 13, 2024	SELL	$57.25 - $69.74 $11,450 - $13,947	-200 Reduced 0.24%	83,001 $4.99 Million
Q3 2023 Nov 13, 2023	BUY	$63.16 - $76.5 $446,667 - $541,008	7,072 Added 9.29%	83,201 $5.59 Million
Q2 2023 Aug 11, 2023	BUY	$46.28 - $75.01 $165,451 - $268,160	3,575 Added 4.93%	76,129 $5.26 Million
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $58,790 - $77,678	-1,354 Reduced 1.83%	72,554 $3.5 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $3.25 Million - $4.64 Million	-83,721 Reduced 53.11%	73,908 $3.69 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $81,221 - $121,565	2,129 Added 1.37%	157,629 $6.43 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $2.36 Million - $3.87 Million	-70,380 Reduced 31.16%	155,500 $8.55 Million
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $584,820 - $908,337	-18,853 Reduced 7.7%	225,880 $8.21 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $953,254 - $1.32 Million	23,171 Added 10.46%	244,733 $11.4 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $38,558 - $55,211	1,092 Added 0.5%	221,562 $11.2 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $1.24 Million - $1.97 Million	47,924 Added 27.77%	220,470 $9.05 Million
Q1 2021 May 14, 2021	SELL	$23.55 - $32.4 $2.86 Million - $3.94 Million	-121,594 Reduced 41.34%	172,546 $5.01 Million
Q4 2020 Feb 16, 2021	SELL	$25.8 - $32.39 $224,976 - $282,440	-8,720 Reduced 2.88%	294,140 $8.28 Million
Q3 2020 Nov 16, 2020	SELL	$27.5 - $39.61 $347,875 - $501,066	-12,650 Reduced 4.01%	302,860 $9.35 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $11.4 Million - $13.4 Million	315,510 New	315,510 $13.4 Million

Others Institutions Holding LEGN

# of Institutions

227

Shares Held

76.3M

Call Options Held

199K

Put Options Held

342K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.98B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Account

Capital International Sarl Legend Biotech Corp Transaction History